Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Allergic Rhinitis and Conjunctivitis
Do you retest for environmental aeroallergens when patients have relocated within the US between vastly different climates?
Related Questions
How do you address the discrepancy between traditional allergy skin testing and the Rinkel skin test results?
How do you manage recurrent epistaxis from nasal steroids?
When initiating patients on Ragwitek, Odactra, and Grastek and the plan is to continue on all 3 tablets for the next 5 years instead of only for seasons, how far apart from each one do you give the initial dose?
With regard to cat immunotherapy, if testing is positive for cat pelt and cat hair, do you include include 50% pelt and 50% hair if doing immunotherapy?
Do you consider the efficacy of different nasal sprays when prescribing for allergic rhinitis or conjunctivitis?
Have you observed adverse mental health side effects in patients who start montelukast?
Are there certain clinical features that help you choose between benralizumab and mepolizumab for EGPA in clinical practice?
What is your approach to biologic selection in a patient with resistant/persistent ABPA?
Does food sensitivity testing for IgG subclasses help guide your management of food allergy?
Would you still consider omalizumab for CSU with angioedema in a patient with Factor V Leiden deficiency?
